117. Li SY, Liu LH, Jia HZ, Qiu WX, Rong L, Cheng H, Zhang XZ (2014) A pH-responsive
prodrug for real-time drug release monitoring and targeted cancer therapy. Chem Commun 50
(80):11852–11855
118. Fernandez A, Vermeren M, Humphries D, Subiros-Funosas R, Barth N, Campana L,
MacKinnon A, Feng Y, Vendrell M (2017) Chemical modulation of in vivo macrophage
function with subpopulation-specific fluorescent prodrug conjugates. ACS Cent Sci 3
(9):995–1005
119. Kumar R, Kim EJ, Han J, Lee H, Shin WS, Kim HM, Bhuniya S, Kim JS, Hong KS (2016)
Hypoxia-directed and activated theranostic agent: imaging and treatment of solid tumor.
Biomaterials 104:119–128
120. Yuan Y, Zhang CJ, Liu B (2015) A platinum prodrug conjugated with a photosensitizer
with aggregation-induced emission (AIE) characteristics for drug activation monitoring
and combinatorial photodynamic-chemotherapy against cisplatin resistant cancer cells.
Chem Commun 51(41):8626–8629
121. Shin WS, Han J, Verwilst P, Kumar R, Kim JH, Kim JS (2016) Cancer targeted enzymatic
theranostic prodrug: precise diagnosis and chemotherapy. Bioconjug Chem 27(5):1419–1426
122. Cao Y, Pan R, Xuan W, Wei Y, Liu K, Zhou J, Wang W (2015) Photo-triggered fluorescent
theranostic prodrugs as DNA alkylating agents for mechlorethamine release and spatiotemporal monitoring. Org Biomol Chem 13(24):6742–6748
Fluorescence Molecular Imaging of Medicinal Chemistry in Cancer
31